发明名称 COMPOSTO, COMPOSIÇÃO FARMACÊUTICA, INIBIDOR PLK1 E AGENTE ANTITUMORAL
摘要 The present invention relates to a compound represented by Formula [I]: or a pharmaceutically acceptable salt or ester thereof, wherein R 1 and R 2 , which may be the same or different, are each a hydrogen atom, a lower alkyl group, a cycloalkyl group, or the like; R 3 and R 4 , which may be the same or different, are each a hydrogen atom, a lower alkyl group, NR a R b , a phenyl group, a lower alkyl group substituted with a phenyl group, a 4- to 7-membered aliphatic heterocyclic group, a lower alkyl group substituted with a 4- to 7-membered aliphatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group, a lower alkyl group substituted with a 5- or 6-membered aromatic heterocyclic group, or the like; and R 5 is a hydrogen atom, a cyano group, a halogen atom, or a lower alkyl group.
申请公布号 BRPI0718966(A2) 申请公布日期 2014.01.07
申请号 BR2007PI18966 申请日期 2007.12.20
申请人 BANYU PHARMACEUTICAL CO., LTD. 发明人 TAKASHI HASHIHAYATA;MIKAKO KAWAMURA;MORIHIRO MITSUYA;YOSHIYUKI SATOH
分类号 C07D471/04;A61K31/506;A61P35/00;A61P43/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址